Clinical Trial Update: [18F]PSMA-11 PET/CT Phase 3 Clinical Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for [18F]PSMA-11 PET/CT in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [18F]PSMA-11 PET/CT

Snippet

Sponsor: University Hospital, Ghent | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED